When it comes to the end of this year, the harvest season of Rhodiola Rosea and Crenulata both have ended in China. These two scarce herbs are still not successfully cultivated in large scale, so the prices remain high with upward tendency.

Several manufacturers gave up production and closed out for high prices of Rhodiola Crenulata in the harvest season this year, which influenced the market and price, Zhang Junhui, general manager of Hanzhong TRG Biotech told Herbridge.com.

The extract is primarily for the foreign market, including European, American and Asian makret, especially the USA. Owing to easy standards on this extract in the USA, North America remains to be the main demander. The methanol residue is required to be less than 10ppm in Europe, which is a stumping block to expanding in Europe. But if one firm can turn the stumping block into a stepping stone, he will be dominant and competitive on this market. It needs Halal certification in Southeast Asia, so there is a little demand.

The prices of Salidroside and Rosavin see no change compared to the same period of last year. Due to the dumping by some suppliers earlier, the market is recovering steadily. The price is expected to rise around 10 percent, according to herbridge.com.

Copyright:Herbridge Media